Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

DNAse to the Rescue! Clearing Mitochondrial DNA May Have NET Benefits in Lung Transplantation.

Juvet S, Martinu T.

Am J Respir Cell Mol Biol. 2019 Nov 14. doi: 10.1165/rcmb.2019-0390ED. [Epub ahead of print] No abstract available.

PMID:
31726015
2.

Molecular phenotyping of rejection-related changes in mucosal biopsies from lung transplants.

Halloran K, Parkes MD, Timofte IL, Snell GI, Westall GP, Hachem R, Kreisel D, Levine D, Juvet S, Keshavjee S, Jaksch P, Klepetko W, Hirji A, Weinkauf J, Halloran PF.

Am J Transplant. 2019 Nov 2. doi: 10.1111/ajt.15685. [Epub ahead of print]

PMID:
31679176
3.

Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantation.

Nakajima D, Watanabe Y, Ohsumi A, Pipkin M, Chen M, Mordant P, Kanou T, Saito T, Lam R, Coutinho R, Caldarone L, Juvet S, Martinu T, Iyer RK, Davies JE, Hwang DM, Waddell TK, Cypel M, Liu M, Keshavjee S.

J Heart Lung Transplant. 2019 Nov;38(11):1214-1223. doi: 10.1016/j.healun.2019.07.006. Epub 2019 Jul 26.

PMID:
31474491
4.

The impact of first untreated subclinical minimal acute rejection on risk for chronic lung allograft dysfunction or death after lung transplantation.

Levy L, Huszti E, Tikkanen J, Ghany R, Klement W, Ahmed M, Husain S, Fiset PO, Hwang D, Keshavjee S, Singer LG, Juvet S, Martinu T.

Am J Transplant. 2020 Jan;20(1):241-249. doi: 10.1111/ajt.15561. Epub 2019 Sep 6.

PMID:
31397939
5.

A B cell-dependent pathway drives chronic lung allograft rejection after ischemia-reperfusion injury in mice.

Watanabe T, Martinu T, Chruscinski A, Boonstra K, Joe B, Horie M, Guan Z, Bei KF, Hwang DM, Liu M, Keshavjee S, Juvet SC.

Am J Transplant. 2019 Dec;19(12):3377-3389. doi: 10.1111/ajt.15550. Epub 2019 Aug 26.

PMID:
31365766
6.

Donor human leukocyte antigen-G single nucleotide polymorphisms are associated with post-lung transplant mortality.

Lazarte J, Ma J, Martinu T, Levy L, Klement W, White M, Pelling J, Guan Z, Azad S, Tikkanen J, Rao V, Tomlinson G, Delgado D, Keshavjee S, Juvet SC.

Eur Respir J. 2019 Aug 15;54(2). pii: 1802126. doi: 10.1183/13993003.02126-2018. Print 2019 Aug.

PMID:
31164432
7.

Bronchiolitis obliterans syndrome as manifestation of lung GVHD: Not the only one.

Mura M, Juvet S.

Respirology. 2019 Jul;24(7):702. doi: 10.1111/resp.13567. Epub 2019 Apr 19. No abstract available.

PMID:
31004374
8.

Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients-a single-center retrospective cohort study.

Levy L, Tigert A, Huszti E, Saito T, Mitsakakis N, Moshkelgosha S, Joe B, Boonstra KM, Tikkanen JM, Keshavjee S, Juvet SC, Martinu T.

Transpl Int. 2019 Sep;32(9):965-973. doi: 10.1111/tri.13444. Epub 2019 May 15.

PMID:
31002407
9.

Innate Control of Tissue-Reparative Human Regulatory T Cells.

Lam AJ, MacDonald KN, Pesenacker AM, Juvet SC, Morishita KA, Bressler B; iGenoMed Consortium, Pan JG, Sidhu SS, Rioux JD, Levings MK.

J Immunol. 2019 Apr 15;202(8):2195-2209. doi: 10.4049/jimmunol.1801330. Epub 2019 Mar 8.

PMID:
30850479
10.

Molecular assessment of rejection and injury in lung transplant biopsies.

Halloran KM, Parkes MD, Chang J, Timofte IL, Snell GI, Westall GP, Hachem R, Kreisel D, Trulock E, Roux A, Juvet S, Keshavjee S, Jaksch P, Klepetko W, Halloran PF.

J Heart Lung Transplant. 2019 May;38(5):504-513. doi: 10.1016/j.healun.2019.01.1317. Epub 2019 Feb 6.

PMID:
30773443
11.

Cytokine profile in lung transplant recipients with Aspergillus spp colonization.

Herrera S, Gohir W, Foroutan F, Aguilar C, Juvet S, Martinu T, Kumar D, Humar A, Rotstein C, Keshavjee S, Singer LG, Husain S.

Transpl Infect Dis. 2019 Jun;21(3):e13060. doi: 10.1111/tid.13060. Epub 2019 Mar 21.

PMID:
30753747
12.

Lentiviral interleukin-10 gene therapy: Safety and questions.

Liu M, Juvet SC, Medin JA, Martinu T, Oishi H, Keshavjee S.

J Thorac Cardiovasc Surg. 2019 Feb;157(2):818-819. doi: 10.1016/j.jtcvs.2018.10.082. No abstract available.

PMID:
30669243
13.

Neutrophil extracellular traps in ex vivo lung perfusion perfusate predict the clinical outcome of lung transplant recipients.

Caldarone L, Mariscal A, Sage A, Khan M, Juvet S, Martinu T, Zamel R, Cypel M, Liu M, Palaniyar N, Keshavjee S.

Eur Respir J. 2019 Apr 4;53(4). pii: 1801736. doi: 10.1183/13993003.01736-2018. Print 2019 Apr. No abstract available.

PMID:
30655281
14.

Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.

Martinu T, Oishi H, Juvet SC, Cypel M, Liu M, Berry GJ, Hwang DM, Keshavjee S.

Am J Transplant. 2019 Jan;19(1):247-258. doi: 10.1111/ajt.15167. Epub 2018 Nov 29.

15.

A novel combined ex vivo and in vivo lentiviral interleukin-10 gene delivery strategy at the time of transplantation decreases chronic lung allograft rejection in mice.

Oishi H, Juvet SC, Martinu T, Sato M, Medin JA, Liu M, Keshavjee S.

J Thorac Cardiovasc Surg. 2018 Sep;156(3):1305-1315. doi: 10.1016/j.jtcvs.2018.05.003. Epub 2018 May 29.

PMID:
29937159
16.

Sequential broncho-alveolar lavages reflect distinct pulmonary compartments: clinical and research implications in lung transplantation.

Levy L, Juvet SC, Boonstra K, Singer LG, Azad S, Joe B, Cypel M, Keshavjee S, Martinu T.

Respir Res. 2018 May 25;19(1):102. doi: 10.1186/s12931-018-0786-z.

17.

Pentraxin 3 deficiency enhances features of chronic rejection in a mouse orthotopic lung transplantation model.

Yoshida M, Oishi H, Martinu T, Hwang DM, Takizawa H, Sugihara J, McKee TD, Bai X, Guana Z, Lua C, Cho HR, Juvet S, Cypel M, Keshavjee S, Liu M.

Oncotarget. 2018 Jan 3;9(9):8489-8501. doi: 10.18632/oncotarget.23902. eCollection 2018 Feb 2.

18.

Higher M30 and high mobility group box 1 protein levels in ex vivo lung perfusate are associated with primary graft dysfunction after human lung transplantation.

Hashimoto K, Cypel M, Juvet S, Saito T, Zamel R, Machuca TN, Hsin M, Kim H, Waddell TK, Liu M, Keshavjee S.

J Heart Lung Transplant. 2017 Jun 21. pii: S1053-2498(17)31870-3. doi: 10.1016/j.healun.2017.06.005. [Epub ahead of print]

PMID:
28689646
19.

Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry.

Juvet SC, Moshkelgosha S, Sanderson S, Hester J, Wood KJ, Bushell A.

J Vis Exp. 2017 Apr 19;(122). doi: 10.3791/55283.

20.

Syk Regulates Neutrophilic Airway Hyper-Responsiveness in a Chronic Mouse Model of Allergic Airways Inflammation.

Salehi S, Wang X, Juvet S, Scott JA, Chow CW.

PLoS One. 2017 Jan 20;12(1):e0163614. doi: 10.1371/journal.pone.0163614. eCollection 2017.

21.

Safety and Efficacy of Ex Vivo Donor Lung Adenoviral IL-10 Gene Therapy in a Large Animal Lung Transplant Survival Model.

Machuca TN, Cypel M, Bonato R, Yeung JC, Chun YM, Juvet S, Guan Z, Hwang DM, Chen M, Saito T, Harmantas C, Davidson BL, Waddell TK, Liu M, Keshavjee S.

Hum Gene Ther. 2017 Sep;28(9):757-765. doi: 10.1089/hum.2016.070. Epub 2017 Jan 4.

PMID:
28052693
22.

Successful Lung Transplantation From Hepatitis C Positive Donor to Seronegative Recipient.

Khan B, Singer LG, Lilly LB, Chaparro C, Martinu T, Juvet S, Pipkin M, Waddell TK, Keshavjee S, Humar A, Cypel M.

Am J Transplant. 2017 Apr;17(4):1129-1131. doi: 10.1111/ajt.14137. Epub 2017 Jan 16.

23.

Circulating Cell Death Biomarkers May Predict Survival in Human Lung Transplantation.

Hashimoto K, Besla R, Zamel R, Juvet S, Kim H, Azad S, Waddell TK, Cypel M, Liu M, Keshavjee S.

Am J Respir Crit Care Med. 2016 Jul 1;194(1):97-105. doi: 10.1164/rccm.201510-2115OC.

PMID:
26796350
24.

Halofuginone treatment reduces interleukin-17A and ameliorates features of chronic lung allograft dysfunction in a mouse orthotopic lung transplant model.

Oishi H, Martinu T, Sato M, Matsuda Y, Hirayama S, Juvet SC, Guan Z, Saito T, Cypel M, Hwang DM, Keller TL, Whitman MR, Liu M, Keshavjee S.

J Heart Lung Transplant. 2016 Apr;35(4):518-27. doi: 10.1016/j.healun.2015.12.003. Epub 2015 Dec 10.

PMID:
26787621
25.

Quantification of CD4(+) T Cell Alloreactivity and Its Control by Regulatory T Cells Using Time-Lapse Microscopy and Immune Synapse Detection.

Juvet SC, Sanderson S, Hester J, Wood KJ, Bushell A.

Am J Transplant. 2016 May;16(5):1394-407. doi: 10.1111/ajt.13607. Epub 2016 Jan 29.

26.

Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning.

Juvet SC, Whatcott AG, Bushell AR, Wood KJ.

Am J Transplant. 2014 Apr;14(4):750-63. doi: 10.1111/ajt.12647. Epub 2014 Mar 4. Review.

27.

FcRγ controls the fas-dependent regulatory function of lymphoproliferative double negative T cells.

Juvet SC, Thomson CW, Kim EY, Han M, Zhang L.

PLoS One. 2013 Jun 6;8(6):e65253. doi: 10.1371/journal.pone.0065253. Print 2013.

28.

Rejection of tracheal allograft by intrapulmonary lymphoid neogenesis in the absence of secondary lymphoid organs.

Wagnetz D, Sato M, Hirayama S, Matsuda Y, Juvet SC, Yeung JC, Guan Z, Zhang L, Liu M, Waddell TK, Keshavjee S.

Transplantation. 2012 Jun 27;93(12):1212-20. doi: 10.1097/TP.0b013e318250fbf5.

PMID:
23318304
29.

FcRγ promotes T cell apoptosis in Fas-deficient mice.

Juvet SC, Thomson CW, Kim EY, Joe B, Adeyi O, Zhang L.

J Autoimmun. 2013 May;42:80-93. doi: 10.1016/j.jaut.2012.12.002. Epub 2013 Jan 10.

PMID:
23313147
30.

Autocrine IFNγ controls the regulatory function of lymphoproliferative double negative T cells.

Juvet SC, Han M, Vanama R, Joe B, Kim EY, Zhao FL, Jeon C, Adeyi O, Zhang L.

PLoS One. 2012;7(10):e47732. doi: 10.1371/journal.pone.0047732. Epub 2012 Oct 15.

31.

Desquamative interstitial pneumonitis in a patient with systemic lupus erythematosus.

Esmaeilbeigi F, Juvet S, Hwang D, Mittoo S.

Can Respir J. 2012 Jan-Feb;19(1):50-2.

32.

Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions.

Juvet SC, Zhang L.

J Mol Cell Biol. 2012 Feb;4(1):48-58. doi: 10.1093/jmcb/mjr043. Review.

33.

Regulation of antigen-expressing dendritic cells by double negative regulatory T cells.

Gao JF, McIntyre MS, Juvet SC, Diao J, Li X, Vanama RB, Mak TW, Cattral MS, Zhang L.

Eur J Immunol. 2011 Sep;41(9):2699-708. doi: 10.1002/eji.201141428. Epub 2011 Aug 4.

34.

Regulatory CD4(-)CD8(-) double negative T cells.

Kim EY, Juvet SC, Zhang L.

Methods Mol Biol. 2011;677:85-98. doi: 10.1007/978-1-60761-869-0_6.

PMID:
20941604
35.

Rare lung diseases III: pulmonary Langerhans' cell histiocytosis.

Juvet SC, Hwang D, Downey GP.

Can Respir J. 2010 May-Jun;17(3):e55-62. Review.

36.

Prostaglandin E2 signaling through E prostanoid receptor 2 impairs proliferative response of double negative regulatory T cells.

Lee BP, Juvet SC, Zhang L.

Int Immunopharmacol. 2009 May;9(5):534-9. doi: 10.1016/j.intimp.2009.01.023. Epub 2009 Jan 31.

PMID:
19539567
37.

Rare lung disease II: pulmonary alveolar proteinosis.

Juvet SC, Hwang D, Waddell TK, Downey GP.

Can Respir J. 2008 May-Jun;15(4):203-10. Review.

38.

Timing of nocturnal ventricular ectopy in heart failure patients with sleep apnea.

Ryan CM, Juvet S, Leung R, Bradley TD.

Chest. 2008 Apr;133(4):934-40. doi: 10.1378/chest.07-2595. Epub 2008 Feb 8.

PMID:
18263677
39.

Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans.

Juvet SC, McCormack FX, Kwiatkowski DJ, Downey GP.

Am J Respir Cell Mol Biol. 2007 Apr;36(4):398-408. Epub 2006 Nov 10. Review.

40.

Rare lung diseases I--Lymphangioleiomyomatosis.

Juvet SC, Hwang D, Downey GP.

Can Respir J. 2006 Oct;13(7):375-80. Review.

41.

High dose intravenous methylprednisolone in the treatment of severe acute respiratory syndrome.

Mishra S, Lee WM, Bressler B, Juvet SC, Hadjiliadis D.

Can Respir J. 2004 May-Jun;11(4):311-2.

42.

Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy.

Tsang RW, Juvet S, Pintilie M, Hill RP, Wong CS, Milosevic M, Chapman W, Levin W, Manchul LA, Fykes AW.

Clin Cancer Res. 2003 Oct 1;9(12):4387-95. Erratum in: Clin Cancer Res. 2004 Feb 1;10(3):1201.

43.

Outcomes of a natural rubber latex control program in an Ontario teaching hospital.

Tarlo SM, Easty A, Eubanks K, Parsons CR, Min F, Juvet S, Liss GM.

J Allergy Clin Immunol. 2001 Oct;108(4):628-33.

PMID:
11590392

Supplemental Content

Support Center